Translational research
Towards better health


25/01/2017 - Research

A new way to diagnose hereditary cancers is already benefitting patients in the Catalan Health Service thanks to ground-breaking research by the Joint Program on Hereditary Cancer ICO-IDIBELL-IGTP

Researchers of the Joint Program on Hereditary Cancer ICO-IDIBELL-IGTP have designed and tested a new strategy based on next generation sequencing (NGS) for the genetic diagnostics of hereditary cancer. They tested it against other current commercially available NGS methods and the new method gave  better results. Previously patients were only tested for one or a small number of genes but now each patient can be tested for a wide range of genes in one single step and the results analysed using complex computing tools resulting in a much more efficient diagnostic process.  700 patients in the Catalan Health System have already benefitted from the new diagnostic approach


Research in Figures


Principal Investigators


Active projects


Publications with IF


Research Groups


patent family applications


Active clinical trials


IGTP Corporate Video

See our video here

Projecte GCAT

50,000 volunteers participating in one biomedical research project to enable researchers to answer vital questions about our health and improve treatments